Thoma Bravo has completed its sale of Global Healthcare Exchange, a provider of connected healthcare supply chains, to Temasek. Thoma Bravo has retained a minority position in the company.
Global Healthcare Exchange (GHX) is a provider of healthcare focused and cloud-based supply chain management technology and services. GHX offers healthcare providers, suppliers, distributors and group purchasing organizations an open and neutral electronic trading exchange that provides procurement and accounts payable automation, contract and inventory management, vendor credentialing and management, business intelligence, payment management and other supply chain-related tools and services. GHX, led by CEO Bruce Johnson, has employees in the United States, Canada and Europe and is headquartered near Boulder in Louisville, CO (www.ghx.com).
“Over the course of our partnership, GHX has pursued a pro-growth strategy and now maintains a strong position in North American and Europe. Thoma Bravo has worked alongside GHX’s management team to make significant operational improvements and strategic growth investments, with the goal of achieving a leadership position in the healthcare supply chain,” said Seth Boro, a Managing Partner at Thoma Bravo. “We are confident that GHX will continue this trajectory and look forward to continuing to work with GHX in its next phase of growth.”
Thoma Bravo invests from $100 million to $750 million of equity in US-based software and technology enabled services companies that typically have annual EBITDA of greater than $20 million. Transaction types include take-private transactions, buy-outs, corporate carve-outs, recapitalizations and growth equity investments. Thoma Bravo currently manages approximately $17 billion of equity capital and has offices in Chicago and San Francisco (www.thomabravo.com).
“GHX perfectly aligned with Thoma Bravo’s buy and build strategy and our expertise in building market-leading companies in fragmented but consolidating industry sectors,” said Arvindh Kumar, a Principal at Thoma Bravo. “Our partnership with GHX has proven to be another successful investment for us in the healthcare technology space, and is a prime example of the value Thoma Bravo brings to each of our portfolio companies.”
Temasek is a sovereign wealth fund with $197 billion of assets under management. Sectors of interest include telecommunications, media, and technology; financial services; transportation; industrials; consumer; real estate; life sciences and agriculture; energy; and natural resources. The group has 10 offices globally; including New York and San Francisco in the US, London in Europe, Beijing in China, and Mumbai in India. Temasek was founded in 1974 and is headquartered in Singapore (www.temasek.com.sg).
© 2017 Private Equity Professional | July 14, 2017
